🇺🇸 FDA
Patent

US 6306832

Peptide antiestrogen compositions and methods for treating breast cancer

expired A61KA61K38/00A61K48/00

Quick answer

US patent 6306832 (Peptide antiestrogen compositions and methods for treating breast cancer) held by The Regents of the University of California expires Mon Oct 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 23 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
40
CPC classes
A61K, A61K38/00, A61K48/00